Search En menu en ClientConnect
Search
Results
Top 5 search results See all results Advanced search
Top searches
Most visited pages

Signature(s)

Amount
€ 110,000,000
Countries
Sector(s)
The Netherlands : € 110,000,000
Health : € 110,000,000
Signature date(s)
28/04/2023 : € 110,000,000
Link to source

Summary sheet

Release date
23 December 2022
Status
Reference
Signed | 28/04/2023
20220677
Project name
Promoter - financial intermediary
HMC SUSTAINABLE HEALTHCARE
STICHTING HAAGLANDEN MEDISCH CENTRUM
Proposed EIB finance (Approximate amount)
Total cost (Approximate amount)
EUR 175 million
EUR 350 million
Location
Sector(s)
  • Health - Human health and social work activities
Description
Objectives

The first phase of a comprehensive renovation and upgrade of Haaglanden Medical Centre (HMC), a top clinical hospital in The Hague.

Haaglanden Medisch Centrum has developed a long-term development plan to ensure its status as a top clinical hospital, to improve the quality of services at sustainable costs and to optimise the facilities for its patients and staff. Upon completion of the project, expected in 2030, HMC Antoniushove shall provide planned forms of care, in particular low-clinical, low-complexity care and oncological care, whereby HMC Westeinde is and remains the centre for highly complex and acute care. The clinical functions from the Bronovo site will be transferred in phases to the two other hospital sites, and HMC Bronovo will be rehabilitated for a medical use to be defined, including planned outpatient care and diagnostics. The project also aims to improve the environmental efficiency of the three hospital sites.

Additionality and Impact

The project supports the EIB's "Health" policy objective and aims to provide higher quality and more accessible healthcare services, responding to the demographic trends and requirements of the metropolitan region of The Hague. Investments in the health sector generate positive externalities that include, but are not limited to, containment of communicable and non-communicable diseases and their negative effect on individuals, as well as the indirect impact on economic productivity from a healthier workforce and population.


The project covers the investment plan of Stichting Haaglanden Medisch Centrum ("HMC") a top-clinical teaching hospital located in The Hague, in the Netherlands. Two of the existing three hospital sites will be rehabilitated to consolidate the clinical activities in a revised and more efficient layout. Part of the project is the rehabilitation of the third facility, for a future medical use to be defined. The project will improve the efficiency and quality of HMC's healthcare services and is in line with EU and EIB policy objectives for the healthcare sector.


The Bank can provide long-term financings, thereby aligning maturities to the economic life of the investment, and facilitate disbursements over a prolonged period of time, in line with the project's construction timeline. In parallel, the EIB also adds to the depth and length of HMC's funding options, acting alongside commercial and national promotional banks.

Environmental aspects
Procurement

Hospitals are not explicitly mentioned in the EIA Directive 2011/92/EU as amended by 2014/52/EU,though the project is covered by Annex II of the Directive concerning urban development. The Bank's services will verify appraisal during the screening decision of the Competent Authority. It is expected that the project will bear more comprehensive benefits to the community as healthcare is an element of social cohesion and economic development.

The Promoter has been assessed by the EIB as being a private company not being subject to EU rules on public procurement or concessions. However, if at the project appraisal, the EIB were to conclude that the Promoter is subject to the EU public procurement legislation then the Bank would duly inform the Commission Services and would require the Promoter to apply those rules.

Milestone
Under appraisal
Approved
Signed
28 February 2023
28 April 2023
Link to source

Disclaimer

Before financing approval by the Board of Directors, and before loan signature, projects are under appraisal and negotiation. The information and data provided on this page are therefore indicative.
They are provided for transparency purposes only and cannot be considered to represent official EIB policy (see also the Explanatory notes).

Documents

Environmental and Social Data Sheet (ESDS) - HMC SUSTAINABLE HEALTHCARE
Publication Date
7 Mar 2023
Document language
Main Topic
Lending
Document Number
165821342
Document Focus
Environmental Information
Project Number
20220677
Sector(s)
Regions
Countries
Publicly available
Download now

News & Stories

General enquiries and comments

The EIB is committed to open communication and encourages constructive stakeholder input regarding its activities.
Enquiries and comments concerning the EIB’s involvement in a project or the financing facilities, activities, organisation and objectives of the EIB, can be sent to the EIB Infodesk.
Alternatively, the EIB can be contacted through its external offices.
Queries regarding details of a specific project, in particular when it is under appraisal by the EIB, should preferably be addressed directly to project promoters.

Media enquiries

Media-related enquiries can be addressed to the EIB Press Office. Please also visit our Media information section.

Complaints mechanism

Any complaint regarding alleged maladministration can be lodged via the EIB Complaints Mechanism. The European Ombudsman acts as an independent external accountability mechanism of the EIB.

Zero tolerance against fraud and corruption

The EIB has a zero tolerance policy on fraud or corruption. To report allegations of fraud and corruption relating to EIB-financed projects, please contact the Fraud and Investigation division. All complaints will be treated as strictly confidential and handled in line with the EIB investigation procedures and the Anti-Fraud Policy.

Related publications